Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthew A. Beldner
Matthew A. Beldner
Oncology
Internal medicine
Medicine
Phases of clinical research
Pathology
3
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
2017
Clinical Colorectal Cancer
Cynthia G. Leichman
Shannon McDonough
Stephen R. Smalley
Kevin G. Billingsley
Heinz-Josef Lenz
Matthew A. Beldner
Aram F. Hezel
Mario R. Velasco
Katherine A. Guthrie
Charles D. Blanke
Howard S. Hochster
Show All
Source
Cite
Save
Citations (12)
Phase II study of regorafenib (Reg) in patients with previously treated advanced pancreatic cancer (APC).
2017
Journal of Clinical Oncology
John Stuart Salmon
Jimmy J. Hwang
Myra M. Robinson
James Thomas Symanowski
Lloye M. Dillon
Lopamudra Das Roy
Matthew A. Beldner
Kelry Preston
Sharon Buige
Reza Nazemzadeh
Pinku Mukherjee
Farhang Farhangfar
Edward S. Kim
Show All
Source
Cite
Save
Citations (3)
S0713: A phase II study of cetuximab (CET) added to induction chemotherapy (ICT) of oxaliplatin (OX) and capecitabine (CAP), followed by neoadjuvant chemoradiation (NACR) for locally advanced rectal cancer (LARC).
2015
Journal of Clinical Oncology
Cynthia G. Leichman
Shannon McDonough
Stephen R. Smalley
Kevin G. Billingsley
Heinz-Josef Lenz
Matthew A. Beldner
Aram F. Hezel
Mario R. Velasco
Katherine A. Guthrie
Charles D. Blanke
Howard S. Hochster
Show All
Source
Cite
Save
Citations (3)
1